(Q30461472)

6 September 2017

Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. (English)

1 reference

Erratum: Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989

6 September 2017

corrigendum / erratum

1 reference

DOI

10.1038/EJHG.2013.121

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/EJHG.2013.121

author

Gareth Evans

1

1 reference

6 September 2017

Catherine O'Hara

2

1 reference

6 September 2017

Anna Wilding

3

1 reference

6 September 2017

Sarah L Ingham

4

1 reference

6 September 2017

Elizabeth Howard

5

1 reference

6 September 2017

John Dawson

6

1 reference

6 September 2017

Anthony Moran

7

1 reference

6 September 2017

Vilka Scott-Kitching

8

1 reference

6 September 2017

Felicity Holt

9

1 reference

6 September 2017

Susan M Huson

10

1 reference

6 September 2017

22 June 2011

1 reference

European Journal of Human Genetics

6 September 2017

1 reference

6 September 2017

19

1 reference

6 September 2017

11

1 reference

6 September 2017

1187-1191

1 reference

Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

A clinical study of type 1 neurofibromatosis in north west England

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Neurofibromatosis in Gothenburg, Sweden. I. Background, study design and epidemiology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198144

Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2011.113

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2011.113

Mortality of neurofibromatosis in Japan, 1968-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2011.113

Neurofibromatosis type 1 and sporadic optic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2011.113

Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJHG.2011.113

Sarcomas in three generations of a family with neurofibromatosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21694737

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21694737

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/EJHG.2011.113

1 reference

6 September 2017

1 reference

6 September 2017

PubMed publication ID

21694737

1 reference